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Total hip arthroplasty (THA) has become a common pro-
cedure. Every year, around one million patients worldwide 
receive a THA (1). However, surgeons are currently faced 
with a wide range of prostheses alongside a lack of reliable 
and comparable long-term clinical data required to make 
an informed choice (2).
As revision of loose prostheses can be surgically demand-
ing, costly, and is associated with considerable patient 
morbidity (3), proven long-term survival of the implant is 
of critical importance. UK guidelines (4) recommend a revi-
sion rate of ≤10% at 10 years as the current benchmark 
level. As cemented prostheses have been used for longer 
than cementless ones, they have a greater long-term evi-
dence base. Indeed, in the year 2000, it was estimated that 
90-95% of prostheses used in the UK were cemented (4). 
However, similar survival rates between cemented and ce-
mentless implants have now been reported (5, 6).
There are many different types of cementless prosthesis; 
however, these are not all equally effective. A recent review 
of cementless prostheses by Zwartele et al (7) stated that 
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inferior implant designs were blamed for hip failures in all 
reviewed studies, rather than the quality of bone or fixation. 
The importance of implant design is further underlined by 
the finding that modifications to a single femoral stem (Fur-
long HAC stem) considerably increased subsidence in the 
first two years following implantation (8). Naturally, there is 
considerable interest in early markers that are predictive of 
implant failure in order to stop using poorer designs before 
long-term outcome data becomes available.
Many studies have reported stem migration in the distal di-
rection, i.e. subsidence, to be a predictive factor for early 
loosening (9-15). Two-year subsidence rates of 1.2 mm [as 
measured by roentgen stereophotogrammetric analysis 
(RSA) (12)], ≥1.5 mm [as measured by EBRA (16)], or ≥2 mm 
[as measured using a digitising table and software (13, 15)] 
are associated with an increased probability of later aseptic 
loosening of the stem. Using EBRA, similar observations 
over a five-year period allow long-term outcome to be pre-
dicted with an accuracy level of 91% (16).
The aim of this study was to evaluate early subsidence 
of the cementless hydroxyapatite (HA)-coated twinSys®  
femoral stem (Mathys Ltd., Bettlach, Switzerland). The data 
presented are the first mid-term (five-year) subsidence and 
survival data for this stem. To measure subsidence, the 
Ein Bild Roentgen Analyse – Femoral Component Analysis 
(EBRA-FCA) technique was used. Additional radiographic 
and clinical findings are also reported.
METHODS
This was a prospective radiological and clinical follow-
up study on the twinSys® cementless stem. Particular 
emphasis was placed upon measuring early subsidence 
using EBRA-FCA. The Ethics Committee of the Maria 
Middelares Hospital, Gent, Belgium, granted approval for 
this study.
Patients
We examined a consecutive series of patients receiv-
ing primary THA with the cementless twinSys® stem. All 
stems were implanted by the same surgeon (MG) at the 
Maria Middelares Hospital between 1 November 2003 
and 15 April 2005. In all cases, a direct lateral Hardinge 
approach was used, with the patient in a supine posi-
tion. Patients were assessed preoperatively. Follow-ups 
were prospectively scheduled at two, five, 12, 24, and 
60 months.
Our exclusion criteria were: 1) age >85 years; 2) unable or 
unwilling to come to the follow-up consultations.
Implants
Patients received either the twinSys® standard or lateral 
cementless stem combined with various types of cup 
and bearings. The twinSys® triple-tapered femoral stem is 
made of TiAl6V4 and has a plasma-sprayed HA coating. 
Details on the bearing surface material and head diameter 
are presented in Table I.
TABLE I - BASELINE CHARACTERISTICS
Patient details
n 211
Age at operation, years 68.4 (36-85)
Male/female 71 / 140
Weight, kg 73.5 (45-115)
BMI 26.6 (17.1-41.5)
Presenting conditiona
 Osteoarthrosis 200 (91.7%)
 Avascular necrosis 15 (6.9%)
 Congenital hip dysplasia 2 (0.9%)
 Rheumatoid arthritis 1 (0.5%)
Charnley scorea
 A 112 (51.4%)
 B 50 (22.9%)
 C 56 (25.7%)
Stemsa
Type
 Standard stems 83 (38%)
 Lateralised 135 (62%)
Bearing surface
 Alumina on polyethylene 137 (63%)
 Metal on polyethylene 3 (1.5%)
 Metal on metal 77 (35% )
Head diameter
 28 mm 11 (5%)
 32 mm 192 (89%)
 38 mm 13 (6%)
Figures in parentheses are the range for patient details and percentages for 
presenting condition and Charnley score.
aData on 218 THA.
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Clinical assessment
The patients were prospectively assessed using the Harris 
Hip Score (17) and Merle d’Aubigné Score (18).
Radiological assessment
The x-rays were evaluated by an independent orthopaedic 
surgeon (MC) who was not involved in the surgeries.
Radiographs were examined for:
1)  osteolysis, defined as an area of localised progressive 
bone resorption or endosteal erosion (19);
2) radiolucent lines (20);
3)  bone hypertrophy, defined as a thickening of the 
periprosthetic bone (19) and allocated to the Gruen 
zones (21);
4)  subsidence, evaluated by comparing the pre- and 
post-surgery distances between the tip of the tro-
chanter minor and the proximal shoulder of the 
prosthesis (22).
5)  pedestal formation, defined as shelf of endosteal new 
bone at the stem tip partially or completely bridging 
the intramedullary canal (23);
6) heterotopic ossifications (24);
7)  resorption of the calcar (rounding of the medial fem-
oral neck); only second, third- and fourth-degree 
stress shielding with resorption of cortical bone me-
dially, anteriorly or laterally was regarded as stress 
shielding (19).
EBRA measurement
EBRA-FCA is a non-invasive method that utilises single ra-
diographs from different time points to analyse subsidence 
(16, 25, 26). The inherent measurement error is reduced 
by estimating the mean subsidence profile based on well-
defined reference lines. In addition, EBRA-FCA uses three 
parameters (measurements) to assess the comparability of 
pairs of radiographs, and accepts only pairs within chosen 
limits (25). EBRA-FCA has shown good agreement with 
the reference standard RSA, and measurement accuracy 
is very good (<1.5 mm) (25).
All images were processed by the same technician. Mea-
surement errors showing apparent upward movement 
were not altered, as such errors would also occur in the 
other direction. To be included in the analysis, each THA 
required a minimum of four comparable x-rays.
Statistical analysis
Survival of the stem was calculated according to Kaplan-
Meier. To determine the monthly subsidence rate, a linear 
random effects regression model of subsidence against 
time since operation was calculated. To account for the 
curvilinear trend, both a linear and a quadratic term were 
specified. The SAS software procedure ‘Mixed’ was used 
for this purpose, with patients treated as block variable, i.e. 
a compound symmetry covariance structure was specified 
to handle the correlation among patients. Quantile-quantile 
plots and graphs plotting residuals against predicted val-
ues (also known as a Tukey-Anscombe plot) were used to 
judge the assumptions of the model.
RESULTS
Patients
We examined 218 THA (211 patients) performed using the 
twinSys® cementless stem. For baseline characteristics, 
see Table I.
Of the 218 THA, 28 prostheses were implanted in patients 
who died of causes unrelated to THA, and 23 prostheses 
were implanted in patients who were lost to follow-up as 
they were either too old or too disabled to come to follow-
up visits. All twinSys® prostheses were still in situ at the last 
point of contact. There were five revisions. Consequently, 
162 THA (74.3%) remained at five-year follow-up. A de-
tailed breakdown of patient flow is presented in Figure 1.
Clinical and radiological assessments
At five years, 95.2% of the patients had an excellent or a 
good Harris Hip Score (mean: 96.1, range: 35-100). The mean 
Merle d’Aubigné Score reached 17.0 points (range: 9-18). 
Full clinical and radiological data are displayed in Table II.
Stem survival
A Kaplan-Meier analysis with stem revision as the end-
point revealed a 98.4% (95% CI: 97.6-100%) survival rate 
at 5 years (Fig. 2). At five years, there had been two cup 
revisions and three stem revisions recorded. The causes of 
stem revision were aseptic loosening (n = 1) and peripros-
thetic fractures (n = 2).
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Subsidence at two years
At two years, 162 THA had complete radiological follow-
up (856 radiographs). The EBRA algorithm excluded 30 
incomparable radiographs (12 THA). This left 150 THA for 
analysis, with an average of 4.65 (range 3-7) radiographs 
per THA. The mean subsidence was 0.69 mm (95% CI: 
0.53-0.84 mm).
Subsidence at five years
At five years, 111 THA had complete radiological follow-
up (508 radiographs). The EBRA algorithm excluded 28 
Fig. 1 - Study flowchart: 28 patients 
(28 THA) were lost due to death from 
unrelated causes and 23 patients 
(23 THA) were lost to follow-up 
(4 bedridden patients; 16 patients 
who could not be traced or con-
tacted; 3 dissatisfied patients un-
willing to present for follow-up). The 
3 dissatisfied patients all had metal-
on-metal implants, which are now 
recognised to carry a higher risk of 
failure (33).
Fig. 2 - Kaplan-Meier survival curve for stem revision.
TABLE II - RADIOLOGICAL AND CLINICAL FOLLOW-UPS
Radiological follow-up 111 THA
Osteolysis (103 THA with full data)
 No 101 (90.99%)
 Yes 2 (1.94%)
Radiolucent lines (104 THA with full data)
 None 82 (78.85%)
 Zone 1 20 (19.23%)
 Zone 1, zone 7 1 (0.96%)
 Zone 7 1 (0.96%)
Calcar resorption (107 THA with full data)
 No 90 (84.11%)
 Yes 17 (15.89%)
Pedestal Formation (104 THA with full data)
 No 75 (72%)
 Yes 29 (28%)
Heterotopic ossification (108 THA with full data)
 Brooker I 14 (14.81%)
 Brooker II-III 4 (3.7%)
 None 87 (79.81%)
Varus valgus migration (107 THA with full data)
 No 107 (100%)
Clinical Follow-Up 162 THA
Harris Hip Score
 Excellent 97 (60.0%)
 Good 57 (35.2%)
 Fair 7 (4.3%)
 Poor 1 (0.6%)
Merle d’Aubigné Score
 Excellent 111 (68.5%)
 Good 27 (16.6%)
 Fair 20 (12.4%)
 Poor 4 (2.5%)
Data presented as number of THA with percentages in parentheses. Mean ra-
diological follow-up: 63.6 months (range 50.2-82.7 months).
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incomparable radiographs. This left 89 THA for analysis 
with a mean of 5.1 radiographs (range 3-7) per THA. The 
mean subsidence was 0.66 mm (95% CI: 0.43-0.90 mm). 
Of note, the greater 95% confidence limit does not surpass 
the measurement error of the EBRA method (±1 mm) (26). 
The linear random effects regression model of subsidence 
against time is displayed in Figure 3. Example radiographs 
are presented in Figure 4.
Subsidence at last recorded follow-up
Data from the last recorded follow-up [mean ± SD: 46.48 
± 18.42 months; median (interquartile range): 57 (28.5-60) 
months] were available for 164 THA (114 THA in women; 
50 THA in men). The mean subsidence was 0.75 mm (95% 
CI: 0.58-0.92 mm), 16 (9.8%) showed subsidence values of 
>2 mm. There was no significant difference in subsidence 
between genders, as later confirmed in the regression mod-
el, although the non-parametric test pointed to a borderline 
significant effect with females showing smaller subsidence 
(p = 0.044, Wilcoxon test).
DISCUSSION
HA coatings are used in some cementless stems to en-
sure rapid osseointegration and long-term stability. The 
survival rates of fully HA-coated stems have proven to 
be outstanding. In the Norwegian Arthroplasty Register 
1987-2004 (6), <1% revisions were recorded at 4.5 years, 
2.4% revisions at 10 years, and 4.9% revisions at 15 years 
on a total number of 5,130 fully HA-coated stems. The 
15-year survival rate (95.1%) was comparable to the best 
of the cemented stems examined (6).
Subsidence levels of the twinSys® femoral stem through-
out the 5 years of follow-up were substantially lower than 
the 1.5 mm level predictive of later aseptic loosening (16).
In their study on the Accolade cementless stem, White et al 
(27) reviewed the available literature on femoral stem sub-
sidence measured by EBRA-FCA. They presented two-year 
results from eight studies, including their own, showing a 
range of mean 2-year subsidence values from 0.29 mm 
to 4.2 ± 1.5 mm. Thus, the twinSys® subsidence values 
(0.69 mm at two years) are at the lower end of this range.
Our findings on femoral subsidence are broadly in line 
with those reported in studies on successful cementless 
stems analysed using RSA. Campbell et al 2011 (28) re-
ported subsidence of 0.58 mm at two years for the Corail® 
stem. Interestingly, these authors reported subsidence to 
be confined to the first six months following implantation. 
This finding was not replicated here, although it was found 
that the rate of subsidence decreased after 12 months.
The data from this study support the relationship between 
low levels of initial subsidence and improved implant sur-
vival. Of the 218 THA, there was a single case of stem 
revision for aseptic loosening (without subsidence) at five 
Fig. 3 - Shaft subsidence (Y direction) over time with estimated 
regression line.
Fig. 4 - Example radiographs from a 77-year-old female patient 
taken: (a) postoperatively; and (b) at 5 years; (The subsidence level 
was 5.5 mm at 2 years).
a b
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years. The UK National Institute for Clinical Excellence (4) 
recommends a revision rate of ≤10% at 10 years as the 
current benchmark level for prosthesis selection for THA. 
A prosthesis with a revision rate at three years’ follow-up 
that is consistent with this benchmark could also be rec-
ommended (4).
The five-year survival rate reported here (98.4%) is compa-
rable to those reported for other cementless stems, such 
as the five-year survival rate of 98% reported for the Link 
MP (29) and the high survival rate for the CLS® Spotorno 
(6, 19, 30, 31) and Corail® (5, 6, 28) stem.
In addition to the encouraging data on subsidence and 
survival, clinical outcome matched expectations for such a 
procedure (excellent in 60% of patients and good or excel-
lent in 95% of patients).
This study has some key strengths and limitations. The ra-
diological data were assessed by an independent surgeon, 
eliminating any potential bias. Moreover, EBRA-FCA is a 
highly objective and repeatable method of measuring sub-
sidence. The skill and experience of the surgeon and the 
surgical approach used are both known to have a large 
impact upon treatment outcome. Our single-centre study 
using just one approach eliminated these potential con-
founders. Furthermore, single-surgeon series have been 
shown to produce superior results to multi-surgeon series 
(32). Therefore future studies are required in other centres 
before the findings presented here can be generalised. The 
main limitation to this study was the relatively high number 
of patients who were lost to follow-up.
In conclusion, the twinSys® stem appears to display the 
excellent survival and subsidence results previously re-
ported for HA-coated cementless femoral stems. Further 
study is now required in other centres to ensure these re-
sults can be replicated.
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